IL-2 results in enhanced anti-tumoral immunity in vitro as well as in vivo by promoting several immune cells; by contrast, it can also promote growth and protect HNSCC cells from apoptosis [12]. Here, IL2 is linked to head and neck squamous cell carcinoma.